22nd Feb 2011 12:43
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a re-valuation of the cash element of the notional investment held within the US Retirement Savings Plan ("The Plan"), which is notionally held in GSK Ordinary share ADRs, the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned persons on 22 February 2011 of an increase in the notional allocation of Ordinary share ADRs on 18 February 2011 at a price of $39.15 per ADR:-
Dr K Belmonte 4 Mr W C Louv 8 Dr M M Slaoui 17 Dr D Pulman 12 | |
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
22 February 2011
Related Shares:
Glaxosmithkline